Devin Whittemore Smith - 14 Jun 2021 Form 4 Insider Report for YUMANITY THERAPEUTICS, INC. (KANT)

Role
SVP and General Counsel
Signature
/s/ Devin W. Smith
Issuer symbol
KANT
Transactions as of
14 Jun 2021
Net transactions value
$0
Form type
4
Filing time
16 Jun 2021, 17:14:49 UTC
Next filing
03 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KA Stock Option (Right to Buy) Award $0 +58,400 $0.000000 58,400 14 Jun 2021 Common Stock 58,400 $16.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option shall vest on June 14, 2022. The remaining 75% vest in equal monthly installments over the subsequent three years.